Skip to main content

Acceleron Pharma Inc

XLRNDelisted Nov 22, 2021
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001280600

Acceleron Pharma Inc was delisted on Nov 22, 2021; its insiders filed their last Form 4 on Nov 22, 2021; 333 institutions reported holding it in 13F filings for Q3 2021, worth $9.22B in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Acceleron Pharma Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of XLRN: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders110
Shares220 (0.0%)
Value$358$358$0 (0.0%)

New holders (0)

Institutions that held Acceleron Pharma Inc at the end of Q3 2024 but not at the end of Q2 2024.

None.

Sold out (0)

Institutions that held Acceleron Pharma Inc at the end of Q2 2024 and filed for Q3 2024 without it.

None.